c-KIT expression in columnar cell lesions of the breast accompanied by benign and malignant breast diseases

Pathology Research and Practice

Volumn 203, Issue 11, 2007, Pages 765-769

  Polat, Ayse ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Breast; c KIT; Columnar cell lesions

Indexed keywords

STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST DISEASE; BREAST EPITHELIUM; CARCINOMA IN SITU; COLUMNAR EPITHELIUM; CONTROLLED STUDY; CYTOCHEMISTRY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PROTEIN EXPRESSION;

EID: 35148892159     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2007.08.010     Document Type: Article

References (31)

1. Bijker N., Peterse J.L., Duchateau L., et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J. Clin. Oncol. 19 (2001) 2263-2271
2. Dabbs D.J., Carter G., Fudge M., et al. Molecular alterations in columnar cell lesions of the breast. Mod. Pathol. 19 (2006) 344-349
3. Dessauvagie B.F., Zhao W., Heel-Miller K.A., et al. Characterization of columnar cell lesions of the breast: immunophenotypic analysis of columnar alteration of lobules with prominent apical snouts and secretions. Hum. Pathol. 2 (2007) 284-292
4. Diallo R., Rody A., Jackisch C., et al. C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu. Hum. Pathol. 37 (2006) 205-211
5. Eusebi V., Feudale E., Foschini M.P., et al. Long-term follow-up of in situ carcinoma of the breast. Semin. Diagn. Pathol. 11 (1994) 223-235
6. Fraser J.L., Raza S., Chorny K., et al. Columnar alteration with prominent apical snout and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcification. Am. J. Surg. Pathol. 22 (1998) 1521-1527
7. Heinrich M.C., Blanke C.D., Druker B.J., et al. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J. Clin. Oncol. 20 (2002) 1692-1703
8. Ho B.C., and Tan P.H. Flat epithelial atypia: concepts and controversies of an intraductal lesion of the breast. Pathology 37 (2005) 105-111
9. Ko C.D., Kim J.S., Ko B.G., et al. The meaning of the c-KIT proto-oncogene product in malignant transformation in human mammary epithelium. Clin. Exp. Metastasis 20 (2003) 593-597
10. Lux M.L., Rubin B.P., Biase T.L., et al. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am. J. Pathol. 156 (2000) 791-795
11. Miettinen M., and Lasota J. Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 438 (2001) 1-12
12. Moinfar F., Man Y.G., Bratthauer G.L., et al. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium. Cancer 88 (2000) 2072-2081
13. Natali P.G., Nicotra M.R., Sures I., et al. Breast cancer is associated with loss of the c-KIT oncogene product. Int. J. Cancer 11 (1992) 713-717
14. Nielsen T.O., Hsu F.D., Jensen K., et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin. Cancer Res. 10 (2004) 5367-5374
15. Nocka K., Majumder S., Chabot B., et al. Expression of c-KIT gene products in known cellular targets of W mutations in normal and W mutant mice-evidence for an impaired c-KIT kinase in mutant mice. Genes Dev. 3 (1989) 816-822
16. Oyama T., Iijima K., Takei H., et al. Atypical cystic lobule of the breast: an early stage of low-grade ductal carcinoma in-situ. Breast Cancer 7 (2000) 231-326
17. Plummer H., Catlett J., Leftwich J., et al. c-myc expression correlates with suppression of c-KIT protooncogene expression in small cell lung cancer cell lines. Cancer Res. 53 (1993) 4337-4342
18. Robbins P., Pinder S., Klerk N., et al. Histological grading of breast carcinomas: a study of interobserver agreement. Hum. Pathol. 26 (1995) 873-879
19. Schnitt S.J. Columnar cell lesions of the breast. Pathol. Case Rev. 8 (2003) 201
20. Schnitt S.J., and Vincent-Salomon A. Columnar cell lesions of the breast. Adv. Anat. Pathol. 10 (2003) 113-124
21. Schnitt S.J. The diagnosis and management of pre-invasive breast disease: flat epithelial atypia-classification, pathologic features and clinical significance. Breast Cancer Res. 5 (2003) 263-268
22. Simon R., Panussis S., Maurer R., et al. KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations. Clin. Cancer Res. 1 (2004) 178-183
23. Simpson P.T., Gale T., Reis-Filho J.S., et al. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am. J. Surg. Pathol. 29 (2005) 734-746
24. Tan P.H., Jayabaskar T., Yip G., et al. p53 and c-KIT (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study. Mod. Pathol. 18 (2005) 1527-1534
25. F.A. Tavassoli, P. Devilee, editors: World Health Organization Classification of Tumors. Pathology and Genetics of Tumour of the Breast and Female Genital Organs. IARC Press, Lyon, 2003. pp. 60-73.
26. Tian Q., Frierson H.F., Krystal G.W., et al. Activating c-KIT gene mutations in human germ cell tumors. Am. J. Pathol. 154 (1999) 1643-1647
27. Tsuda H., Morita D., Kimura M., et al. Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid-tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation. Cancer Sci. 96 (2005) 48-53
28. Tsuda H., Tani Y., Weisenberger J., et al. Frequent KIT and epidermal growth factor receptor overexpressions in undifferentiated-type breast carcinomas with 'stem-cell-like' features. Cancer Sci. 96 (2005) 333-339
29. Tsuura Y., Suzuki T., Honma K., et al. Expression of c-KIT protein in proliferative lesions of human breast: sexual difference and close association with phosphotyrosine status. J. Cancer Res. Clin. Oncol. 128 (2002) 239-246
30. Ulivi P., Zoli W., Medri L., et al. c-KIT and SCF expression in normal and tumor breast tissue. Breast Cancer Res. Treat. 83 (2004) 33-42
31. Yared M.A., Middleton L.P., Meric F., et al. Expression of c-KIT proto-oncogene product in breast tissue. Breast J. 10 (2004) 323-327